Page last updated: 2024-08-22

butoxamine and Disease Models, Animal

butoxamine has been researched along with Disease Models, Animal in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gamelli, RL; Hasan, S; Mosier, MJ; Muthumalaiappan, K; Szilagyi, A1
Bratasz, A; Guan, Z; Huang, K; Mandrekar-Colucci, S; Nash, MS; Popovich, PG; Powell, ND; Rabchevsky, AG; Reader, B; Shawler, T; Sheridan, JF; Weil, Z; Wells, J; Whitacre, CC; Zhang, Y1
Furuya, H; Hirai, K; Inoue, S; Kato, H; Kawaguchi, M1
Alzate, WD; Calderon, GM; Cook, KM; Kotamarti, S; Livingston, DH; Mohr, AM; Pasupuleti, LV; Sifri, ZC1

Other Studies

4 other study(ies) available for butoxamine and Disease Models, Animal

ArticleYear
Discrete β-adrenergic mechanisms regulate early and late erythropoiesis in erythropoietin-resistant anemia.
    Surgery, 2017, Volume: 162, Issue:4

    Topics: Adrenergic Antagonists; Anemia; Animals; Burns; Butoxamine; Disease Models, Animal; Erythropoiesis; Male; Mice; Nadolol; Propanolamines; Propranolol; Receptors, Adrenergic, beta

2017
Autonomic dysreflexia causes chronic immune suppression after spinal cord injury.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2013, Aug-07, Volume: 33, Issue:32

    Topics: Adrenergic beta-2 Receptor Antagonists; Animals; Antigens, CD; Autonomic Dysreflexia; Blood Pressure; Butoxamine; Colon; Corticosterone; Disease Models, Animal; Epinephrine; Female; Hormone Antagonists; Humans; Immune System Diseases; Immunosuppression Therapy; Mice; Mifepristone; Norepinephrine; Ovalbumin; Physical Stimulation; Spinal Cord Injuries; T-Lymphocytes; Telemetry

2013
The effects of beta-adrenoceptor antagonists on proinflammatory cytokine concentrations after subarachnoid hemorrhage in rats.
    Anesthesia and analgesia, 2009, Volume: 108, Issue:1

    Topics: Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Butoxamine; Disease Models, Animal; Inflammation Mediators; Interleukin-6; Male; Metoprolol; Neuroprotective Agents; Propranolol; Rats; Rats, Sprague-Dawley; Subarachnoid Hemorrhage; Time Factors; Tumor Necrosis Factor-alpha

2009
Does selective beta-1 blockade provide bone marrow protection after trauma/hemorrhagic shock?
    Surgery, 2012, Volume: 152, Issue:3

    Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Bone Marrow; Butoxamine; Contusions; Disease Models, Animal; Hematopoietic Stem Cells; Lung Injury; Male; Propanolamines; Protective Agents; Rats; Rats, Sprague-Dawley; Shock, Hemorrhagic

2012